- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Diana Lee Farmer
Total 1211 results
-
Jacqueline Garcia, MDNational Institutes of Health (NIH)RecruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant | MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)United States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; BioNTech SE; Oncovir, Inc.RecruitingLymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Candel Therapeutics, Inc.RecruitingGlioma | Glioblastoma | Astrocytoma | Malignant Glioma of Brain | Brain Cancer | Brain Tumor | Glioblastoma Multiforme | Ependymoma | Ganglioglioma | Oligodendroglioma | Malignant Astrocytoma | Anaplastic Oligodendroglioma of Brain (Diagnosis) | Mixed Oligo-Astrocytoma | Pylocytic/Pylomyxoid AstrocytomaUnited States
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Charles H. Hood FoundationCompletedOther CancerUnited States
-
Dana-Farber Cancer InstituteAdenoid Cystic Carcinoma Research Foundation; The V FoundationCompletedAdenoid Cystic CarcinomaUnited States
-
Amy C. Sherman, MDMerck Sharp & Dohme LLCCompletedCytomegalovirus InfectionsUnited States
-
Beth Israel Deaconess Medical CenterNovartis; Dana-Farber Cancer Institute; Duke UniversityCompletedRenal Cell Carcinoma | Renal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedMixed Mullerian Tumors of the UterusUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; University of Massachusetts, BostonCompleted
-
Dana-Farber Cancer InstituteNational Center for Complementary and Integrative Health (NCCIH)CompletedDysphagia | Carcinomas, Squamous CellUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; AstraZeneca; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterCompletedProstate CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedLymphoma | Multiple Myeloma | Acute Myelogenous LeukemiaUnited States
-
Brigham and Women's HospitalDana-Farber Cancer Institute; United States Department of DefenseNot yet recruiting
-
Bruno BockornyDana-Farber Cancer Institute; Agenus Inc.Not yet recruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal AdenocarcinomaUnited States
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaRecruitingBreast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast CancerUnited States
-
Centro de Estudio de Estado y SociedadDana-Farber Cancer Institute; Deakin UniversityCompleted
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteCompletedRenal CancerUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine...Active, not recruitingChronic Graft Versus Host Disease | Chronic GVHD | Complications of Organ Transplant Stem CellsUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Patrick Ott, MD, PhDBristol-Myers Squibb; Oncovir, Inc.Active, not recruiting
-
Lumicell, Inc.National Cancer Institute (NCI); Massachusetts General Hospital; Dana-Farber...Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Hodgkin's DiseaseUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AmgenCompletedColorectal CancerUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedRenal Cell Carcinoma | Neoplasm MetastasesUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteCompletedSarcoma | Small Intestine Cancer | Ovarian Cancer | Endometrial Cancer | Desmoid Tumor | Adult Malignant Fibrous Histiocytoma of BoneUnited States
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalTerminatedBurkitt Lymphoma | Non-Hodgkins Lymphoma | Atypical Burkitt LymphomaUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
James Cleary, MD, PhDLustgarten Foundation; Arcus Biosciences, Inc.RecruitingPancreatic Cancer | Adenocarcinoma of the Pancreas | Squamous Cell Carcinoma of Pancreas | Adenosquamous Carcinoma of the PancreasUnited States
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteRecruitingAcute Myelogenous LeukemiaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Massachusetts Institute of TechnologyRecruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaActive, not recruitingBreast CancerUnited States
-
Boston Children's HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Schering-PloughCompletedProgeria | Hutchinson-Gilford SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Columbia University; Schering-PloughCompletedGlioblastoma | GliomasUnited States
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States